StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck consolidated Latin America Revenue ($M) ($M)

Postgres DB segment_values

QuarterlyAnnual
Latest, FY2025
3,410
Period ended Dec 31, 2025
Change on a year earlier
-1.4%
3,459 in FY2024
History
15 years
Since FY2011
Sources
10
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated Latin America Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 20253,410-1.4%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 20243,459+12.1%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 20233,086+19.5%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 20222,582+17.0%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 20212,206+16.7%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 20201,890-6.2%Form 10-K (filed 2022-02-25) ↗
FY2019Dec 31, 20192,015-16.6%Form 10-K (filed 2022-02-25) ↗
FY2018Dec 31, 20182,415+3.2%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 20172,339+8.5%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 20162,155-23.7%SEC Filing ↗
FY2015Dec 31, 20152,825-10.3%SEC Filing ↗
FY2014Dec 31, 20143,151-1.6%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20133,203-5.5%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 20123,389-2.4%Form 10-K (filed 2014-02-27) ↗
FY2011Dec 31, 20113,472–Form 10-K (filed 2014-02-27) ↗

Cite this data

StockData. (2026). Merck Consolidated Latin America Revenue ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_geo_latam_rev

See every metric in the Merck KPI table. Data updated Oct 26, 2026.